How often does lipitor cause liver issues?

Lipitor can cause liver enzyme elevations in clinical trials, but serious liver injury remains rare.

How does Lipitor affect liver enzymes?

Lipitor raises ALT and AST levels in some patients. These increases occur in 0.7% of patients receiving 10 mg daily and in 2.3% of patients receiving 80 mg daily. Most elevations resolve when treatment stops.

What liver problems do patients report?

Patients report cases of hepatitis, cholestasis, and rare liver failure. Spontaneous reports track these events through pharmacovigilance systems, but rates remain low.

When does liver damage appear?

Liver enzyme increases show up in early treatment months. Doctors monitor enzymes at baseline and 12 weeks after starting or increasing dose.

Can other factors raise risk?

Excessive alcohol use, existing liver disease, and certain medications combine with Lipitor to heighten risk. Doctors avoid prescribing to patients with active liver disease.

Why are companies challenging this patent?

Pfizer's basic compound patent on atorvastatin calcium, the active ingredient in Lipitor, expired in 2011. Subsequent patents on specific salt forms and crystalline forms of the drug have faced challenges from generic manufacturers seeking early entry.

When does exclusivity expire?

Exclusivity periods for certain formulations of Lipitor ended by 2012. Generic atorvastatin has been available since 2011, lowering access barriers after the core patent lapsed.

How does Lipitor compare with Crestor?

Crestor raises liver enzyme levels at rates similar zu Lipitor. Both drugs belong to the statin class and share liver monitoring recommendations in their prescribing information.

Can biosimilars enter before patent expiry?

Biosimilars do not apply to Lipitor since it is a small-molecule drug. Generic chemical versions entered the market after 2011.